Concerns
long-term
methotrexate
MTX
neurotoxicity
modifications
intrathecal
leucovorin
rescue
frequency
systemic
MTX
administration
children
acute lymphoblastic leukemia
study
neurocognitive outcomes
neuroradiologic
evidence
leukoencephalopathy
children
treated with
intense
central nervous system
therapy
P9605
CNS-directed
treatment
intensive consolidation
P9201
children
Pediatric Oncology Group
acute lymphoblastic leukemia
years
diagnosis
evidence
CNS leukemia
diagnosis
ACCL0131
P9201
P9605
Magnetic resonance imaging scans
standard neuropsychological tests
years
treatment
P9605
patients
leukoencephalopathy
compared
P9201
patients
confidence interval
confidence interval
identified
years
treatment
patients
scored
Verbal
Performance IQ
Children
studies
attention problems
P9605
children
scored
neurocognitive measures
treated
P9201
measures
measures
concerns
intensive
MTX
exposure
CNS
late effects
